You are here: Industry Insights > vaccine

News List

Touchlight to Supply GMP dbDNA to Support University of Nottingham’s Clinical Study for a Next-Generation Vaccine for Zika Virus Biotech Newswire
August 22, 2024
Touchlight announced the clinical supply of its proprietary dbDNA™ to the University of Nottingham for research and development of a next-generation DNA vaccine targeting the Zika virus.
The Growth of Vaccines Beyond Infectious Disease Suzanne Elvidge
April 19, 2024
Vaccination for infectious diseases saves two to three million lives a year worldwide, according to the World Health Organization (WHO).
University of Liverpool to Use Touchlight’s Rapid Enzymatic dbDNA in Fully Personalised Neoantigen Cancer Vaccine Clinical Study PharmaSources
April 07, 2024
Touchlight announced an agreement with University of Liverpool for the use of dbDNA in the development of a fully-personalised therapeuticneoantigen DNA vaccine for patients with non-small cell lung cancer.
ProBioGen and DIOSynVax Partner to Manufacture Groundbreaking Multivalent Vaccine for Hemorrhagic Fever PharmaSources
April 01, 2024
ProBioGen’s MVA CR19vector will be used to deliver the three HF vaccine antigens.
Africa Vaccine Manufacturing Plans Receive Major Boost SHEM OIRERE
January 19, 2024
Africa’s plan to manufacture at least 60% of its own vaccines to reduce dependence on imports has received a major boost after a financing initiative was launched to support investment in expanded vaccine production and supply within continent.
Breakthroughs in Melanoma Immunotherapy & RNA Vaccines Daivd Orchard Webb/PharmaSources
July 03, 2023
Melanoma is a type of skin cancer that develops from pigment-producing cells called melanocytes.
New Improvement in Universal Vaccines and Long-acting Neutralizing Antibodies PharmaSources/Yefenghong
May 25, 2022
COVID-19 has spread rapidly since the winter of 2019, and even today, the whole world is still shrouded in its haze.
Is mRNA Vaccine the Source of Intricacies of "Mysterious Hepatitis"? PharmaSources/Yefenghong
May 23, 2022
3 years into the COVID-19 pandemic, it has had a significant impact on human health and economic development. Based on WHO statistics, as of April 22, there are approximately 497 million confirmed patients and 6.179 million deaths in the world because of
Chinese Pharmaceutical Companies Entering the DC Vaccine Market Under the Support of Tens of Millions of Financing PharmaSources/Yefenghong
May 23, 2022
Which can be applied to the treatment of cancers and even the COVID-19 infection.
The Oral Vaccine Market and Technology David Orchard-Webb
May 12, 2022
A vaccine is a biologic that improves immunity to disease. Vaccination is considered the most effective means of controlling infectious disease-related morbidity and mortality.